← Leaderboards
Marc A Simon
University Of Pittsburgh At Pittsburgh
$5,233,623
Attributed
$5,233,623
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2016–22$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,233,623 · 2
By mechanism
R01$3,213,011 · 1
P01$2,020,612 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Michael R Pinsky$13,601,966
- Sruti Shiva$9,895,872
- Francisco Jose Schopfer$8,044,712
- Alison Morris$31,399,077
- Karen A Norris$27,323,771
Others in their field
Top investigators on “Pressure”
- David R. Weir · University Of Michigan At Ann Arbor$95,888,102
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$94,073,024
- Gregory S Boebinger · Florida State University$87,341,624
- Alex Lacerda · Florida State University$85,941,624
- Lawrence Corey · Fred Hutchinson Cancer Center$63,779,481
- Georgia D Tomaras · Fred Hutchinson Cancer Center$62,271,232
Research focus
PressurePatient PopulationPhenotypeInsightMetabolicOralLeftClinical TrialsHeart FailureHypoxemiaLung DiseasesBaseMetabolic SyndromeNitritesCategoriesEfracBlood CapillariesClinical DataBlood VesselsHeart DiseasesHemodynamicsCardiac Catheterization ProceduresLungPrograms
Grant awards (10)
Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction$576,734
R01 · FY2022 · AG · contact PI
Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction$657,956
R01 · FY2021 · AG · contact PI
A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction$664,604
R01 · FY2020 · AG · contact PI
Clinical Core$405,829
P01 · FY2020 · HL · contact PI
A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction$664,604
R01 · FY2019 · AG · contact PI
Clinical Core$405,830
P01 · FY2019 · HL · contact PI
A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction$649,113
R01 · FY2018 · AG · contact PI
Clinical Core$405,829
P01 · FY2018 · HL · contact PI
Clinical Core$403,453
P01 · FY2017 · HL · contact PI
Clinical Core$399,671
P01 · FY2016 · HL · contact PI